Farmacosmo S.p.A. (BIT:COSMO)
Italy · Delayed Price · Currency is EUR 0.4800
+0.0110 (2.35%)
Last updated: Jul 27, 2026, 11:23 AM CET
Farmacosmo Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 19 | 18 | 37 | 27 | 73 | - | |
Market Cap Growth | -8.75% | -51.76% | 37.03% | -63.68% | - | - |
Enterprise Value | 25.08 | 24.07 | 40.99 | 30.74 | 70.04 | 0 |
Last Close Price | 0.48 | 0.45 | 0.94 | 0.69 | 1.95 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 36.30 | 36.30 | 36.30 | 65.00 | - |
PEG Ratio | - | 0.59 | 0.59 | 0.59 | 0.59 | - |
PS Ratio | 0.33 | 0.34 | 0.57 | 0.37 | 1.10 | - |
PB Ratio | 3.52 | 3.23 | 3.45 | 2.06 | 4.22 | - |
P/TBV Ratio | - | - | - | - | 66.07 | - |
P/FCF Ratio | 35.11 | 33.20 | - | - | - | - |
P/OCF Ratio | 33.62 | 31.80 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.45 | 0.46 | 0.64 | 0.42 | 1.05 | - |
EV/EBITDA Ratio | - | - | 116.72 | - | - | - |
EV/FCF Ratio | 47.25 | 45.35 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.27 | 0.27 | 0.06 | 0.10 | 0.06 | 0 |
Debt / EBITDA Ratio | - | - | 20.88 | - | - | - |
Debt / FCF Ratio | 14.51 | 14.24 | - | - | - | - |
Net Debt / Equity Ratio | 1.21 | 1.21 | 0.40 | 0.13 | -0.29 | 1.46 |
Net Debt / EBITDA Ratio | -3.81 | -2.18 | 11.99 | -3.89 | 9.10 | 0.95 |
Net Debt / FCF Ratio | 12.69 | 12.45 | -1.93 | -0.31 | 18.56 | -3.30 |
Asset Turnover | 1.79 | 1.78 | 1.89 | 1.92 | 3.31 | 12.10 |
Inventory Turnover | 5.84 | 5.84 | 5.71 | 9.37 | 16.55 | 32.67 |
Quick Ratio | 0.50 | 0.50 | 0.42 | 0.63 | 0.91 | - |
Current Ratio | 0.78 | 0.78 | 0.97 | 1.06 | 1.17 | - |
Return on Equity (ROE) | -57.09% | -57.09% | -23.43% | -22.88% | -20.06% | 54.32% |
Return on Assets (ROA) | -25.04% | -25.04% | -6.71% | -8.07% | -7.61% | 13.79% |
Return on Invested Capital (ROIC) | -62.03% | -54.79% | -14.08% | -19.67% | -18.63% | 136.55% |
Return on Capital Employed (ROCE) | -56.25% | -56.25% | -15.25% | -16.91% | -15.16% | 127.46% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
FCF Yield | 2.85% | 3.01% | - | - | - | - |
Dividend Yield | - | 0.00% | 0.00% | 0.00% | -21.11% | - |
Payout Ratio | - | 0.00% | 0.00% | 0.00% | 1158.99% | 0.00% |
Buyback Yield / Dilution | - | 0.12% | 0.00% | -3.23% | -54931.64% | - |
Total Shareholder Return | - | 0.12% | 0.00% | -3.23% | -54952.76% | - |